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The response of myocardiai lactate and hypoxan- 
thine metabolism during percutaneous transiuminai 
coronary angiopiasty was studied in a series of 15 
patients undergoing this procedure. A minimum of 
4 balloon inflations was performed per patient with 
an average duration per occlusion of 49 f  11 sec- 
onds (mean f  standard deviation) for a total occiu- 
sion time of 192 f  40 seconds. 
Thermodiiution coronary venous blood flow 
measured in the great cardiac vein decreased from 
control values of 72 f  4 mi/min (mean f  standard 
error of the mean) to 47 f  10 mi/min with the 
fourth coronary occlusion (p <O-005). Arteriove- 
nous lactate and hypoxanthine showed peak differ- 
ences during the reactive hyperemia after the first 
2 occlusions which did not increase after subse- 
quent occlusions. Within minutes after the proce- 
dure, lactate and hypoxanthine effiux was no iong- 
er seen, demonstrating the reversibility of the met- 
abolic disturbances after repeated ischemia. 
The results of this study indicate that there is no 
permanent alteration in lactate or hypoxanthine 
metabolism after percutaneous transiuminai coro- 
nary angiopiasty with 4 coronary occlusions of 40 
to 60 seconds’ duration, with a total occlusion time 
of 192 & 40 seconds. 
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ntil recently, the assessment of alteration in 
U myocardial metabolism in humans early after an abrupt occlusion of a major coronary artery has 
not been feasible. Percutaneous transluminal coronary 
angioplasty (PTCA), however, now provides a unique 
opportunity to study the time course of these metabolic 
changes during the transient interruption of coronary 
flow by the balloon occlusion sequence in patients with 
l-vessel disease and without angiographically demonstra- 
ble collateral circulation.1,2 The need to detect any per- 
sisting metabolic or mechanical dysfunction becomes of 
even greater concern as the number of dilated vessels and 
the duration of balloon inflation tend to increase, thereby 
enhancing both the extent and the severity of ischemia. 
The risk exists that the damage induced by the interven- 
tion may exceed its benefit. 
During and after ischemia, there is in the heart, as 
well as in other muscles, excessive adenosine triphosphate 
(ATP) breakdown. This degradation of ATP causes an 
efflux of breakdown products, which are able to pass 
through the cell membrane into the blood before sig- 
nificant amounts of enzymes appear. The purine deriva- 
tives adenosine, inosine and hypoxanthine are therefore 
thought to be early markers for ischemia.3 Because of 
high activities of adenosine deaminase and low amounts 
of nucleoside phosphorylase and xanthine oxidase in the 
heart and blood, hypoxanthine seems most promising as 
an early marker for myocardial ischemia.4 
Recently, high-pressure liquid chromatography 
(HPLC) came into use for the determination of nucleo- 
sides and purine bases in the whole blood,5,6 facilitating 
the determination of purine derivatives, in particular hy- 
poxanthine. This new technical development prompted us 
to investigate the myocardial release of hypoxanthine 
during coronary angioplasty. 
Patients: All patients met the following criteria: a 
brief history of angina pectoris (<l year), an isolated 
obstructive lesion in 1 coronary vessel (the left anterior 
descending artery) and an accessible stenosis of < 1 cm in 
length. All patients were candidates for coronary artery 
bypass graft surgery because of disabling angina, but 
were selected for angioplasty rather than surgery because 
of their anatomy. 
Fifteen patients (12 men and 3 women, aged 38 to 74 
years) were studied. Of these, 4 were in New York Heart 
Association class II, 9 in class III and 2 in class IV. In all, 
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the ejection fraction was >50% and none of them had 
wall motion abnormalities on their diagnostic left ventric- 
ulograms at rest. Four transluminal dilatations were per- 
formed with a total duration of occlusion of 192 f 40 
seconds (mean f standard deviation). All patients in the 
study underwent successful reperfusion with the 4 epi- 
sodes of PTCA. All patients in this study gave their 
informed consent and there were no complications direct- 
ly related to the research procedure. 
Percutaneous transluminal coronary angioplasty: 
PTCA was performed according to the technique of 
Gruentzig, with the equipment of Schneider, via the fem- 
oral route. In all cases the pressure gradient across the 
obstructive lesion was recorded before, during and after 
balloon inflation. The dilatation catheters were either the 
20 to 30 or 20 to 37 models. The inflation pressure ranged 
from 2 to 12 atm, whereas the individual duration of 
occlusion ranged from 40 to 60 seconds. Coronary angi- 
ography with nonionic contrast medium (metrizamide) 
was performed before and at the end of the PTCA proce- 
dure. 
Premeditation consisted of aspirin, and all patients 
received 3 mg of isosorbide dinitrate selectively into the 
left main coronary artery during control coronary arteri- 
ography, but the coronary flow measurements we report 
were not performed within the periods of the drug’s effect 
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FIGURE 1. Isocratic high-pressure liquid chromatographic 
separation of nucleosides and purine bases from a patient be- 
fore and after a single transluminal occlusion. AU = absorp- 
tion units; HYP = hypoxanthine; PTCA = percutaneous trans- 
luminal coronary angioplasty. 
on the coronary circulation. Therapy with P-blocking 
drugs was not discontinued. During the procedure, hepa- 
rin and low molecular weight dextran were administered 
intravenously. 
Lactate and hypoxanthine determinations: Blood 
samples were obtained from the great cardiac vein and 
the left coronary artery at 6 consecutive measurement 
periods: before the PTCA procedure, 5 to 10 seconds 
after each transluminal occlusion and 5 minutes after 
termination-of the PTCA procedure. Five minutes were 
allowed between each dilatation for recovery. 
Blood (1.5 ml) for lactate measurements was rapidly 
deproteinized with an equal volume of cold 8% perchloric 
acid (HC104) and centrifuged. After centrifugation, the 
supernatant fluids were stored at -2O’C. Lactate in the 
supernatant was analyzed enzymatically ‘according to 
Apstein et al7 with the AutoAnalyzer (Technicon, Tarry- 
town, New York). Standard curves were made with lithi- 
um lactate in 4% HC104 
An isocratic HPLC system was used for the estima- 
tion of purine nucleosides and oxypurines in blood.6 Use 
was made of a reversed-phase column. Because nucleo- 
tides derived from erythrocytes affected the separation, 
these.compounds had to be removed. The method of 
Chatterjee et al was used8 with some minor differences. 
We applied 1.5 ml of the deproteinized, neutralized blood 
sample onto a prewashed column of A1203 (0.6 g) in a 
Pasteur pipette, and eluted it with 5.0 ml 10 mmol/liter 
Tris/HCl, pH 7.4. For faster elution, a vacuum was ap- 
plied to a sampling manifold. Twelve samples were treat- 
ed at the same time. A Waters M 6000 HPLC* was used 
with a WISP 710 B autosampler,* a model 440 UV- 
detector* fixed at 254 nm wavelength connected to a BD 
41 recorder.7 A 4 mm I.D. X 30 cm prepacked p Bonda- 
pak/Cis column,* particle size 10 pm, was used,in these 
studies. Chromatographic conditions were adapted from 
earlier work9: 200 ~1 samples were eluted from this col- 
umn with 10 mmol/liter NH,+Hz POd/CHsOH (lO:l, 
v/v), pH 5.50. The flow rate was 60 ml/hour (Fig. 1). 
Flow and resistance measurements: Great cardiac 
vein blood flow was measured by the continuous thermo- 
dilution method before and after the PTCA procedure as 
well as during each transluminal occlusion. In the begin- 
ning of the investigation the location of the external 
thermistor, in the great cardiac vein, was verified by 
injection of 3 ml of contrast material. Each recording of 
blood flow during coronary angioplasty began before bal- 
loon inflation and was interrupted at the moment of bal- 
loon deflation. Coronary vascular resistance (CVR) was 
calculated for great cardiac veinlo using the mean arterial 
pressure (MAP) and blood flow in the great cardiac vein: 
CVR = MAP/Flow (mm Hg/ml/min) 
Statistical analysis: Results are expressed as mean f 
standard error of the mean. Comparison between results 
before and after PTCA and occlusion conditions were 
evaluated using analysis of variance for repeated mea- 
surements. When overall significance was found, multi- 
*Millipore Waters, Bedford, Massachusetts. 
tKipp en Zonen, Delft, the Netherlands. 
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ple comparisons were significantly different at the 0.05 
level. 
RESULTS 
Coronary hemodynamic measurements: The results 
of the coronary hemodynamic observations are summa- 
rized in Figure 2 and Table I. During the initial dilata- 
tion, the mean duration of balloon inflation was 44 f 4 
seconds. During the subsequent dilatations the duration 
of inflation was slightly increased up to 49 f 6 seconds. 
FIGURE 2. Changes in great cardiac vein 
flow and resistance during 4 transluminal 
occlusions. GCV = great cardiac vein; Post 
= postangioplasty; Pre = before angio- 
plasty; PTCA = percutaneous transluminal 
coronary angioplasty. 
Occlusion pressure did not change throughout these oc- 
clusion times of 40 to 60 seconds and there was a high 
degree of reproducibility of the occlusion pressure during 
these successive occlusions (Table I). The mean blood 
flow in the great cardiac vein before the first inflation 
was 72 f 4 ml/min, decreasing to 47 f 10 ml/min (p 
<0.003) during the fourth inflation and increasing slight- 
ly to 93 f 8 ml/min (p <0.03) after completion of the 
PTCA procedure (Table I). Great cardiac vein coronary 
vascular resistance was 1.42 f 0.18 mm Hg/ml/min 
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LE I Coronary Hemodynamics and Metabolic Disturbances During Sequential Transluminal Occlusion (15 Patients) 
Duration of occlusion (set) 
Occlusion pressure (mm Hg) 
GCV flow (ml/min) 
Resistance (mm Hg/ml/min) 
Arterial lactate (mM) 
GCV lactate (mM) 
Art-GCV lactate (mM) 
Arterial hypoxanthine (pM) 
GCV hypoxanthine (PM) 
Art-GCV hypoxanthine (wM) 
Before 
PTCA 
- 
- 
72&4 
1.42zkO.18 
0.75f0.15 
0.59 f0.12 
0.18hO.06 
3.410.7 
3.0~0.6 
0.3io.3 
First 
44f4" 
24f4 
51f6+ 
2.0*0.3+ 
0.67 f0.16 
1.8f0.4* 
-1.1 *0.3+ 
3.0f0.7 
5.2f0.8§ 
-2.2 *0.7+ 
Occlusion 
Second Third Fourth 
After 
P-I-CA 
5453 
23f3 
52f6+ 
2.1*0.3+ 
0.65*0.12 
1.6f0.3§ 
-0.91f0.185 
3.3 zkO.6 
7.8f 1.4* 
-4.5f 1.4* 
50*4 
21f2 
4%*7* 
2.2$.0.4* 
0.71f0.14 
1.3f0.3' 
-0.60*0.17* - 
2.9 kO.8 
4.2% 1.06 
-1.4f0.7 - 
49f6 
25f5 
47*10* 
2.3f0.6* 
l.Of0.3 
1.8f0.6+ 
-0.%&0.4* 
3.0f 1.4 
4.4f 1.2+ 
-1.5f0.4 
- 
93f8+ 
1.02+0.11 
0.64*00.12 
0.58-10.13 
0.07 f0.03 
3.8f0.7 
3.7 f0.7 
0.2f0.44 
*Mean f standard error of the mean. 
t p < 0.05; * p < 0.005; 5 p < 0.001 vs before PTCA. 
Ati = arterial; GCV = great cardiac vein; PTCA = percutaneous transluminal coronary angioplasty. 
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before balloon inflation, 2.3 f 0.6 by the end of the fourth 
inflation (p <O.OOS) and 1.02 f 0.11 after completion of 
the PTCA procedure (Table I). 
Lactate aind hypoxanthine metabolism: The arterio- 
venous lactate measurements are listed in Table I and 
shown in Figure 3. The control measurements showed a 
difference of +O. 18 mM, which decreased to -1.1 and 
-0.91 mM, after the first and the second dilatations, 
respectively. After the third dilatation the lactate differ- 
ence was -0.60 mM, which was not significantly differ- 
ent from the values recorded after the first and the second 
dilatation. As a first approximation, the, amount of lac- 
tate lost from the ischemic tissue during the 4 consecutive 
occlusions seems to be more or less constant and at least 
did not increase with the time. During the 4 consecutive 
transluminal occlusions, an average increase of hypoxan- 
thine in the great cardiac vein, from 3.0 f 0.6 to 5.6 f 1.1 
PM, (p <O.Ol) was observed, which fell off after comple- 
tion of the PTCA procedure. The arterial levels of these 
compounds remained constant during transluminal oc- 
clusion. The myocardial arterial-great cardiac vein dif- 
ference of hypoxanthine changed from 0.3 f 0.3 PM 
before angioplasty at rest to -2.4 f 1.2 PM (p <O.Ol) 
during sequential transluminal occlusions. Even if not 
statistically significant, a trend for hypoxanthine release 
to be reduced during occlusions 3 and 4 compared with 
occlusion 1 or 2 was observed. Significant production of 
hypoxanthine, calculated either as arteriovenous differ- 
ence or extraction, only took place after the first 2 trans- 
luminal occlusions, whereas hypoxanthine release was 
absent 5 minutes after completion of the PTCA proce- 
dure. 
DISCUSSION 
Puiine versus lactate release as a marker for ischek 
mia during transluminal coronary occlusion in humans: 
Ischemia can be defined as a situation in which coronary 
blood flow cannot meet the tissue demand.” As a conse- 
quence of the ensuing oxygen deficiency, the balance 
between ATP production and usage is disturbed.12 ATP 
(and creatine phosphate) levels fa11,3J3 creatine, adeno- 
sine diphosphate (ADP), phosphate and hydrogen ion 
levels increase,14-l6 glycolysis rate is enhanced17J8 and 
lactate levels rise. Shortly thereafter, potassium ion, hy- 
drogen ion and lactate are released into the coronary 
venous blood. 
ATP is converted to ADP and adenosine monophos- 
phate (AMP), which is broken down to adenosine, ino- 
sine, hypoxanthine, xanthine and urate (Fig. 4). The 
AMP catabolites pass the cell membrane.19-22 Thus, a 
slight decrease of ATP results in an immediate increase in 
AMP catabolites, and this release can be used to monitor 
myocardial ATP breakdown. 
We believed, therefore, that measuring myocardial 
arteriovenous differences of blood hypoxanthine levels 
could give insight into the metabolic state of the heart4; 
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FIGURE 3. Changes in arterial and venous 
concentration of hypoxanthine and lactate 
during transluminal occlusion. Abbrevia- 
tions as in Figure 2. 
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the method used here makes it possible to measure a normoxia, lactate is preferentially taken up by the 
number of AMP catabolites in blood. In fact, since the heart.28 In fact, lactate released from a local ischemic 
196Os, several studies have discussed the release of purine area can be metabolized by the surrounding normoxic 
components during ischemia or anoxia.4,6,23-27 Lactate as tissue.17 The formation and removal of lactate is also 
a marker of ischemia, has several disadvantages. During influenced by blood fatty acid levels, acidosis and by 
FIGURE 4. Myocardial adenosine triphos- 
phate (ATP) catabolism. The main path- 
ways are: (1) ATPase; (2) adenylate ki- 
nase; (3) !F-nucleotidase; (4) adenosine 
deaminase; (5) nucleoside phosphorylase; 
(6) xanthine oxidase (a)/dehydrogenase 
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FIGURE 5. Examples of mean and phasic intracoronary Doppler signal recorded before, during and after balloon inflation. Reac- 
tive hyperemia occurs after each balloon deflation but its extent and time course are variable during the sequential occlusions 
and thereby could affect the ~onc~ntrat~o~ of the ischemic catabolites during the sampling period. 
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hyperglycemia, 29 all metabolic conditions likely to be 
present during angioplasty. 
Time of blood withdrawal and potential methodolog- 
ic limitations: In our patients, blood samples were ob- 
tained 5 to 10 seconds after the start of deflation. Coro- 
nary sinus potassium ion concentration has been mea- 
sured continuously in patients undergoing angioplasty of 
significant stenoses of the left anterior descending coro- 
nary arteries.30 The recordings obtained from these pa- 
tients showed that, although coronary sinus potassium 
ion levels did not change significantly during coronary 
occlusion, a transient increase occurred when the occlu- 
sion was removed. After reduction of the pressure in the 
balloon the coronary sinus potassium ion levels began to 
increase within 8 seconds. This fits approximately with 
the timing of peak reactive hyperemia observed by our- 
selves and by Rothman et a131 and corresponds with the 
timing of blood withdrawal in this study using a thermo- 
dilution technique. 
More pronounced reactive hyperemia developed when 
the residual functional coronary stenosis associated with 
the deflated PTCA balloon was reduced by subsequent 
dilatation.‘T31 In a previous study, we1 demonstrated that 
the mean hyperemic increase in great cardiac vein flow 
was 55% after the first dilatation and 91% after the third 
dilatation. We recently used an intracoronary Doppler 
velocity probe mounted on the angioplasty balloon cathe- 
ter to analyze beat by beat the reactive hyperemic 
phase.32 This new methodologic approach made us more 
aware of the changing pattern of hyperemia, in terms of 
time course and extent, during repeated occlusion as part 
of the ongoing angioplasty procedure (Fig. 5). 
What was observed in this clinical setting probably 
differs from the (reproducible) reactive hyperemia ob- 
served in the experimental laboratory when transient oc- 
clusion of an otherwise healthy vessel (nonstenotic) is 
induced by an external snare or clamp. Since the left 
anterior descending artery flow was not recorded during 
the sampling period, results were not expressed in terms 
of lactate and hypoxanthine efflux. Therefore, the varia- 
tion in lactate and hypoxanthine concentration in the 
great cardiac vein observed during the 4 sequential occlu- 
sions might have been considerably affected by dilutional 
phenomena related to the changing pattern of the reac- 
tive hyperemia. However, despite these methodologic 
limitations, it appears that the release of lactate and hy- 
poxanthine from the ischemic tissue, during the last oc- 
clusions, does not increase with sequential occlusions. The 
fact that hypoxanthine washout drops off after the third 
inflation while lactate does not, could nevertheless be 
related to complex biochemical processes. 
Dunn et a1,33 studied the temporal relation between 
reactive hyperemic blood flow, reduction in myocardial 
high-energy phosphate stores and removal of lactate in 
dogs. In the endocardium, where the greatest lactate 
changes occur during occlusion, the lactate level was still 
significantly above control after 30 seconds of reactive 
hyperemia when approximately three-fourths of the re- 
sponse had occurred. In contrast, a return of the high- 
energy phosphate stores to control level was already ap- 
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parent at the time of the peak hyperemic flow when only 
one-fourth of the response had occurred. We speculate 
that different responses to ischemia of the glycolytic and 
purine pathways are responsible for the somewhat differ- 
ent lactate and hypoxanthine profiles observed (Fig. 3). 
The great cardiac vein lactate and hypoxanthine returned 
to control levels at the end of the PTCA procedure. This 
indicates that the metabolic changes induced by PTCA 
are quickly reversible. 
Metabolism after repetitive episodes of brief ische- 
mia: Previous work34,35 indicates that repetitive episodes 
of brief ischemia do not produce a cumulative depletion 
of high-energy phosphate compounds. The content of 
nucleotide pools at any point in time is determined by the 
rate of synthesis vs demand. The failure to demonstrate a 
progressive decrease in nucleotide pools during subse- 
quent ischemic episodes after an initial ischemic episode 
might be explained by a decreased degradation of nucleo- 
tides during the subsequent ischemic episodes. 
The mechanism for the putative decrease in coronary 
nucleotide degradation rate during subsequent episodes 
of ischemia is unclear, but several explanations have been 
proposed to account for this finding.36m39 There is growing 
evidence for compartmentation of myocardial nucleotide 
pool~.~~,~~ The different compartments in the cell may 
have different susceptibilities to depletion during myocar- 
dial ischemia. Susceptible pools may have been depleted 
during the first ischemic episode, with more resistant 
pools remaining intact during subsequent ischemic epi- 
sodes of the same duration. 
Besides these adaptive metabolic mechanisms, other 
hemodynamic factors have to be considered. Rentrop et 
a140 demonstrated the appearance of a previously absent 
coronary collateral circulation during balloon inflation. 
This apparent recruitment of collaterals might modulate 
metabolism during angioplasty although its functional 
significance is not yet well defined. The occlusion pres- 
sure measured distally to the stenosis, during balloon 
inflation, correlates well with the existence of collaterals 
demonstrable before or during angioplasty.41,42 However, 
Probst et a141 and Meier et a142 did not observe any 
change in coronary occlusion pressure during serial occlu- 
sions. The absence of any increase in coronary sinus and 
great cardiac vein flow during serial occlusions precludes 
the gradual recruitment of collateral circulation during 
repeated occlusions, which might have explained a possi- 
ble change in lactate and hypoxanthine efflux. 
CONCLUSION 
The crucial conclusion to be drawn from our observa- 
tions is that metabolic disturbances induced by repeated 
myocardial ischemia in humans are quickly reversible, 
provided they are of short durations (<90 seconds). 
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